Inventor · disambiguated record

Cody A. Desjardins

Also filed as: DESJARDINS CODY A

33 granted patents·36 pending applications·582 citations·filing 2019–2025

98Inventor score

Technology areasC12N A61K C07K A61P C12Y

Files withDYNE THERAPEUTICS INC68 DYNE THERAPEUTICS LNC1

Top patents by PatentIndex Score

69 records

0199US12370264B1Complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and method of delivering oligonucleotide to a subjectDYNE THERAPEUTICS INC·Filed 2025·Granted Jul 29, 2025·2 cites·30 claims
0299US12329824B1Muscle targeting complexes and uses thereof for treating dystrophinopathiesDYNE THERAPEUTICS INC·Filed 2025·Granted Jun 17, 2025·4 cites·30 claims
0399US12319743B2Complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and method of delivering oligonucleotide to a subjectDYNE THERAPEUTICS INC·Filed 2024·Granted Jun 3, 2025·5 cites·30 claims
0499US12239717B2Muscle targeting complexes and uses thereof for treating dystrophinopathiesDYNE THERAPEUTICS INC·Filed 2024·Granted Mar 4, 2025·13 cites·30 claims
0599US12239716B2Muscle targeting complexes and uses thereof for treating dystrophinopathiesDYNE THERAPEUTICS INC·Filed 2024·Granted Mar 4, 2025·13 cites·30 claims
0699US12173078B2Complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotideDYNE THERAPEUTICS INC·Filed 2024·Granted Dec 24, 2024·14 cites·30 claims
0799US12144867B2Muscle targeting complexes and uses thereof for treating dystrophinopathiesDYNE THERAPEUTICS INC·Filed 2024·Granted Nov 19, 2024·14 cites·19 claims
0899US12144868B2Muscle targeting complexes and uses thereof for treating dystrophinopathiesDYNE THERAPEUTICS INC·Filed 2024·Granted Nov 19, 2024·14 cites·19 claims
0999US12102687B2Muscle targeting complexes and uses thereof for treating myotonic dystrophyDYNE THERAPEUTICS INC·Filed 2024·Granted Oct 1, 2024·17 cites·30 claims
1099US12097263B2Muscle targeting complexes and uses thereof for treating myotonic dystrophyDYNE THERAPEUTICS INC·Filed 2024·Granted Sep 24, 2024·18 cites·21 claims
1199US12018087B2Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and methods of delivering oligonucleotide to a subjectDYNE THERAPEUTICS INC·Filed 2023·Granted Jun 25, 2024·23 cites·27 claims
1299US11986537B2Muscle targeting complexes and uses thereof for treating dystrophinopathiesDYNE THERAPEUTICS INC·Filed 2023·Granted May 21, 2024·24 cites·19 claims
1399US11969475B2Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophyDYNE THERAPEUTICS INC·Filed 2023·Granted Apr 30, 2024·25 cites·30 claims
1499US11911484B2Muscle targeting complexes and uses thereof for treating myotonic dystrophyDYNE THERAPEUTICS INC·Filed 2021·Granted Feb 27, 2024·28 cites·22 claims
1599US11844843B2Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophyDYNE THERAPEUTICS INC·Filed 2023·Granted Dec 19, 2023·30 cites·30 claims
1699US11839660B2Anti-transferrin receptor antibody and uses thereofDYNE THERAPEUTICS INC·Filed 2023·Granted Dec 12, 2023·30 cites·16 claims
1799US11771776B2Muscle targeting complexes and uses thereof for treating dystrophinopathiesDYNE THERAPEUTICS INC·Filed 2022·Granted Oct 3, 2023·32 cites·19 claims
1899US11759525B1Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophyDYNE THERAPEUTICS INC·Filed 2022·Granted Sep 19, 2023·32 cites·22 claims
1999US11679161B2Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophyDYNE THERAPEUTICS INC·Filed 2022·Granted Jun 20, 2023·38 cites·25 claims
2099US11672872B2Anti-transferrin receptor antibody and uses thereofDYNE THERAPEUTICS INC·Filed 2022·Granted Jun 13, 2023·37 cites·21 claims
2199US11648318B2Anti-transferrin receptor (TFR) antibody and uses thereofDYNE THERAPEUTICS INC·Filed 2022·Granted May 16, 2023·37 cites·9 claims
2299US11638761B2Muscle targeting complexes and uses thereof for treating Facioscapulohumeral muscular dystrophyDYNE THERAPEUTICS INC·Filed 2022·Granted May 2, 2023·47 cites·24 claims
2399US11633498B2Muscle targeting complexes and uses thereof for treating myotonic dystrophyDYNE THERAPEUTICS INC·Filed 2022·Granted Apr 25, 2023·37 cites·30 claims
2498US12280122B2Muscle targeting complexes and uses thereof for treating myotonic dystrophyDYNE THERAPEUTICS INC·Filed 2024·Granted Apr 22, 2025·5 cites·24 claims
2597US11931421B2Muscle targeting complexes and formulations for treating myotonic dystrophyDYNE THERAPEUTICS INC·Filed 2023·Granted Mar 19, 2024·26 cites·7 claims
2695US12128109B2Muscle targeting complexes and formulations for treating dystrophinopathiesDYNE THERAPEUTICS INC·Filed 2023·Granted Oct 29, 2024·17 cites·28 claims
2792US2025360223A1Muscle targeting complexes and uses thereof for treating dystrophinopathiesDYNE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
2892US2025382375A1Muscle-targeting complexes and uses thereofDYNE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
2990US12440574B2Muscle targeting complexes and formulations for treating myotonic dystrophyDYNE THERAPEUTICS INC·Filed 2024·Granted Oct 14, 2025·0 cites·22 claims
3090US12403203B2Muscle targeting complexes and uses thereof for treating dystrophinopathiesDYNE THERAPEUTICS INC·Filed 2024·Granted Sep 2, 2025·0 cites·19 claims
3188US2025367310A1Muscle targeting complexes and formulations for treating myotonic dystrophyDYNE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
3286US12440575B2Muscle targeting complexes and uses thereof for treating dystrophinopathiesDYNE THERAPEUTICS INC·Filed 2025·Granted Oct 14, 2025·0 cites·30 claims
3386US12428487B2Complexes comprising an anti-transferrin receptor antibody linked to an oligonicleotide and method of delivering oligonucleotide to a subjectDYNE THERAPEUTICS INC·Filed 2025·Granted Sep 30, 2025·0 cites·30 claims
3485US12460011B2Complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and method of delivering an oligonucleotide to a subjectDYNE THERAPEUTICS INC·Filed 2025·Granted Nov 4, 2025·0 cites·28 claims
3584US2025339553A1Muscle targeting complexes and formulations for treating myotonic dystrophyDYNE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
3680US12397062B2Muscle targeting complexes and uses thereof for treating dystrophinopathiesDYNE THERAPEUTICS INC·Filed 2025·Granted Aug 26, 2025·0 cites·30 claims
3777US12496352B2Muscle targeting complexes and uses thereof for treating myotonic dystrophyDYNE THERAPEUTICS INC·Filed 2025·Granted Dec 16, 2025·0 cites·18 claims
3871US2025057972A1Muscle targeting complexes and formulations for treating dystrophinopathiesDYNE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
3965US2024382513A1Muscle targeting complexes and uses thereof for modulation of genes associated with muscle healthDYNE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
4065US2023203180A1Muscle targeting complexes and uses thereof for modulation of genes associated with muscle healthDYNE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
4165US2025249117A1Dosing of muscle targeting complexes for treating myotonic dystrophyDYNE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
4264US2024318177A1Muscle targeting complexes and uses thereof for treating dystrophinopathiesDYNE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
4364US2024382609A1Muscle targeting complexes and uses thereof for treating dystrophinopathiesDYNE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
4464US2025099603A9Muscle targeting complexes and uses thereof for treating friedreich's ataxiaDYNE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
4564US2024318176A1Muscle targeting complexes and uses thereof for treating dystrophinopathiesDYNE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
4664US2025249116A1Muscle targeting complexes and uses thereof for treating myotonic dystrophyDYNE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
4764US2024209119A1Muscle targeting complexes and uses thereof for treating dystrophinopathiesDYNE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
4864US2025025570A1Muscle targeting complexes for treating facioscapulohumeral muscular dystrophyDYNE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
4964US2024368296A1Muscle targeting complexes and uses thereof for treating dystrophinopathiesDYNE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
5064US2024294921A1Muscle targeting complexes and uses thereof for treating pompe diseaseDYNE THERAPEUTICS INC·Filed 2022·Application pending·0 cites

Showing the top 50 of 69 patent records by PatentIndex Score.

Join the waitlist — get patent alerts

Get an alert when Cody A. Desjardins files or is granted a new patent.

We store only your email — no account needed. See our privacy policy.

Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →